Linked Life Data

8708717

Source:http://linkedlifedata.com/resource/pubmed/id/8708717

Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:8708717rdf:typepubmed:Citationlld:pubmed
pubmed-article:8708717lifeskim:mentionsumls-concept:C1257890lld:lifeskim
pubmed-article:8708717lifeskim:mentionsumls-concept:C0034656lld:lifeskim
pubmed-article:8708717lifeskim:mentionsumls-concept:C0332174lld:lifeskim
pubmed-article:8708717lifeskim:mentionsumls-concept:C0016360lld:lifeskim
pubmed-article:8708717lifeskim:mentionsumls-concept:C0023413lld:lifeskim
pubmed-article:8708717lifeskim:mentionsumls-concept:C0030231lld:lifeskim
pubmed-article:8708717lifeskim:mentionsumls-concept:C1522484lld:lifeskim
pubmed-article:8708717lifeskim:mentionsumls-concept:C1274040lld:lifeskim
pubmed-article:8708717lifeskim:mentionsumls-concept:C1527249lld:lifeskim
pubmed-article:8708717lifeskim:mentionsumls-concept:C0036525lld:lifeskim
pubmed-article:8708717lifeskim:mentionsumls-concept:C2603343lld:lifeskim
pubmed-article:8708717lifeskim:mentionsumls-concept:C1096776lld:lifeskim
pubmed-article:8708717lifeskim:mentionsumls-concept:C0206012lld:lifeskim
pubmed-article:8708717lifeskim:mentionsumls-concept:C0205195lld:lifeskim
pubmed-article:8708717lifeskim:mentionsumls-concept:C2348563lld:lifeskim
pubmed-article:8708717lifeskim:mentionsumls-concept:C0205179lld:lifeskim
pubmed-article:8708717pubmed:issue8lld:pubmed
pubmed-article:8708717pubmed:dateCreated1996-9-6lld:pubmed
pubmed-article:8708717pubmed:abstractTextTo determine the most effective dose of leucovorin (folinic acid [FA]) within a weekly bolus fluorouracil (FU) schedule, we conducted a randomized multicenter trial to compare therapeutic effects and toxicity of high-dose FA versus low-dose FA combined with FU at equal doses in both treatment groups.lld:pubmed
pubmed-article:8708717pubmed:languageenglld:pubmed
pubmed-article:8708717pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8708717pubmed:citationSubsetIMlld:pubmed
pubmed-article:8708717pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8708717pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8708717pubmed:statusMEDLINElld:pubmed
pubmed-article:8708717pubmed:monthAuglld:pubmed
pubmed-article:8708717pubmed:issn0732-183Xlld:pubmed
pubmed-article:8708717pubmed:authorpubmed-author:Meyer zum...lld:pubmed
pubmed-article:8708717pubmed:authorpubmed-author:BernhardHHlld:pubmed
pubmed-article:8708717pubmed:authorpubmed-author:MichaelisJJlld:pubmed
pubmed-article:8708717pubmed:authorpubmed-author:KnuthAAlld:pubmed
pubmed-article:8708717pubmed:authorpubmed-author:JägerEElld:pubmed
pubmed-article:8708717pubmed:authorpubmed-author:BernhardGGlld:pubmed
pubmed-article:8708717pubmed:authorpubmed-author:KleinOOlld:pubmed
pubmed-article:8708717pubmed:authorpubmed-author:HeikeMMlld:pubmed
pubmed-article:8708717pubmed:authorpubmed-author:LautzDDlld:pubmed
pubmed-article:8708717pubmed:issnTypePrintlld:pubmed
pubmed-article:8708717pubmed:volume14lld:pubmed
pubmed-article:8708717pubmed:ownerNLMlld:pubmed
pubmed-article:8708717pubmed:authorsCompleteYlld:pubmed
pubmed-article:8708717pubmed:pagination2274-9lld:pubmed
pubmed-article:8708717pubmed:dateRevised2009-11-3lld:pubmed
pubmed-article:8708717pubmed:meshHeadingpubmed-meshheading:8708717-...lld:pubmed
pubmed-article:8708717pubmed:meshHeadingpubmed-meshheading:8708717-...lld:pubmed
pubmed-article:8708717pubmed:meshHeadingpubmed-meshheading:8708717-...lld:pubmed
pubmed-article:8708717pubmed:meshHeadingpubmed-meshheading:8708717-...lld:pubmed
pubmed-article:8708717pubmed:meshHeadingpubmed-meshheading:8708717-...lld:pubmed
pubmed-article:8708717pubmed:meshHeadingpubmed-meshheading:8708717-...lld:pubmed
pubmed-article:8708717pubmed:meshHeadingpubmed-meshheading:8708717-...lld:pubmed
pubmed-article:8708717pubmed:meshHeadingpubmed-meshheading:8708717-...lld:pubmed
pubmed-article:8708717pubmed:meshHeadingpubmed-meshheading:8708717-...lld:pubmed
pubmed-article:8708717pubmed:meshHeadingpubmed-meshheading:8708717-...lld:pubmed
pubmed-article:8708717pubmed:meshHeadingpubmed-meshheading:8708717-...lld:pubmed
pubmed-article:8708717pubmed:meshHeadingpubmed-meshheading:8708717-...lld:pubmed
pubmed-article:8708717pubmed:meshHeadingpubmed-meshheading:8708717-...lld:pubmed
pubmed-article:8708717pubmed:meshHeadingpubmed-meshheading:8708717-...lld:pubmed
pubmed-article:8708717pubmed:meshHeadingpubmed-meshheading:8708717-...lld:pubmed
pubmed-article:8708717pubmed:meshHeadingpubmed-meshheading:8708717-...lld:pubmed
pubmed-article:8708717pubmed:meshHeadingpubmed-meshheading:8708717-...lld:pubmed
pubmed-article:8708717pubmed:meshHeadingpubmed-meshheading:8708717-...lld:pubmed
pubmed-article:8708717pubmed:meshHeadingpubmed-meshheading:8708717-...lld:pubmed
pubmed-article:8708717pubmed:meshHeadingpubmed-meshheading:8708717-...lld:pubmed
pubmed-article:8708717pubmed:year1996lld:pubmed
pubmed-article:8708717pubmed:articleTitleWeekly high-dose leucovorin versus low-dose leucovorin combined with fluorouracil in advanced colorectal cancer: results of a randomized multicenter trial. Study Group for Palliative Treatment of Metastatic Colorectal Cancer Study Protocol 1.lld:pubmed
pubmed-article:8708717pubmed:affiliationII. Medizinische Klinik, Hämatologie-Onkologie, Krankenhaus Nordwest, Frankfurt, Germany.lld:pubmed
pubmed-article:8708717pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:8708717pubmed:publicationTypeClinical Triallld:pubmed
pubmed-article:8708717pubmed:publicationTypeComparative Studylld:pubmed
pubmed-article:8708717pubmed:publicationTypeRandomized Controlled Triallld:pubmed
pubmed-article:8708717pubmed:publicationTypeMulticenter Studylld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8708717lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8708717lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8708717lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8708717lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8708717lld:pubmed